Abstract
Abstract
The accumulation of cholesterol is a general feature of cancer tissue, and recent evidence suggests that cholesterol plays critical roles in the progression of cancers, including breast, prostate, and colorectal cancers. The dysregulation of metabolic pathways, including those involved in cholesterol biosynthesis, is implicated in tumor development and cancer progression. Lipid rafts are highly dynamic cholesterol-enriched domains of the cell membrane, involved in various cellular functions, including the regulation of transmembrane signaling at the cell surface. It was recently demonstrated that lipid rafts also play critical roles in cancer cell adhesion and migration. This review focuses on our current understanding of how cholesterol regulation, lipid rafts, and dysregulated cholesterol biosynthesis contribute to cancer development and progression, and the therapeutic potential of cholesterol lowering for cancer prevention and treatment.
Subject
Clinical Biochemistry,Molecular Biology,Biochemistry
Reference192 articles.
1. the risk of colorectal cancer New;Poynter;Engl J Med,2005
2. Potential role of nonstatin cholesterol lowering agents;Trapani;IUBMB Life,2011
3. Lipid content of tumors;Yasuda;Clin Invest,1932
4. del and Intracellular triggering of Fas aggregation and recruitment of apoptotic molecules into Fas - enriched rafts in selective tumor cell apoptosis;Gajate;Exp Med,2004
Cited by
159 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献